Literature DB >> 2189402

Identification and characterization of endothelin converting activity in cultured bovine endothelial cells.

K Ohnaka1, R Takayanagi, T Yamauchi, H Okazaki, M Ohashi, F Umeda, H Nawata.   

Abstract

Using a specific and sensitive radioimmunoassay (RIA) for the carboxyl terminal tail of endothelin (ET) (His16-Trp21), we have confirmed the presence of the converting activity from synthetic human big ET-1 to ET-1 in the homogenate of cultured bovine aortic endothelial cells. The optimal pHs for the converting activities were found at pH 3.0 and pH 7.0. The activity at pH 3.0 was completely inhibited by pepstatin A, whereas the activity at pH 7.0 was not affected by known various protease inhibitors except EDTA and EGTA. When the products from big ET-1 were analyzed on an ODS and a CN columns, only ET-1 was detected at pH 7.0, but various ET-like immunoreactivities other than ET-1 were detected at pH 3.0. These findings strongly suggest that mature ET-1 is formed from big ET-1 in the endothelial cells by a metal-dependent neutral protease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2189402     DOI: 10.1016/0006-291x(90)91146-j

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Solution conformation of human big endothelin-1.

Authors:  M L Donlan; F K Brown; P W Jeffs
Journal:  J Biomol NMR       Date:  1992-09       Impact factor: 2.835

2.  Contractile effect of big endothelin-1 and its conversion to endothelin-1 in rabbit cerebral arteries.

Authors:  J Petersson; G C Hanson; B F Lindberg; E D Högestätt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

3.  Heterologous in vivo processing of human preproendothelin 1 into bioactive peptides.

Authors:  M S Fabbrini; A Vitale; C Patrono; M Zamai; F Vaghi; V Caiolfa; L Monaco; L Benatti
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

Review 4.  Endothelin.

Authors:  Yoshifumi Kawanabe; Surya M Nauli
Journal:  Cell Mol Life Sci       Date:  2010-09-17       Impact factor: 9.261

5.  Comparison of haemoconcentration induced by big endothelin-1 and endothelin-1 in mice.

Authors:  H Okumura; N Ashizawa; F Kobayashi; K Arai; R Asakura; N Ashikawa; A Matsuura
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

6.  Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin.

Authors:  A C Le Monnier de Gouville; I Cavero
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

7.  The endothelin-converting enzyme from human umbilical vein is a membrane-bound metalloprotease similar to that from bovine aortic endothelial cells.

Authors:  K Ahn; K Beningo; G Olds; D Hupe
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

8.  Endothelin and endothelium-derived relaxing factor control of basal renovascular tone in hydronephrotic rat kidneys.

Authors:  E Gulbins; J Hoffend; A P Zou; M S Dietrich; K Schlottmann; A Cavarape; M Steinhausen
Journal:  J Physiol       Date:  1993-09       Impact factor: 5.182

9.  Regional differences in endothelin converting enzyme activity in rat brain: inhibition by phosphoramidon and EDTA.

Authors:  T D Warner; G P Budzik; T Matsumoto; J A Mitchell; U Förstermann; F Murad
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

10.  Contractile activity of endothelin precursors in the isolated gallbladder of the guinea-pig: presence of an endothelin-converting enzyme.

Authors:  B Battistini; M Woods; L J O'Donnell; T D Warner; R Corder; A Fournier; M J Farthing; J R Vane
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.